Ahmed Eltelbany, MD: Outcomes for IBD Patients With Obesity

Patients with obesity have higher costs and longer hospital stays for IBD.

Patients with obesity often face a number of comorbidities, including diabetes, cardiovascular disease, and inflammatory bowel disease (IBD).

With those comorbidities often comes is an increased risk of mortality, longer hospital stays, and increased medical costs.

In an abstract presented during the 2022 American College of Gastroenterology (ACG) Annual Meeting in Charlotte, a team of investigators from the Cleveland Clinic examined some of the outcomes for patients with obesity and IBD compared to non-obese patients with IBD.

In an interview with HCPLive®, Ahmed Eltelbany, MD, Cleveland Clinic, explained the findings and how this data could be utilized for future research.

The result of the nearly 400,000 patient study show the cohort of patients with obesity and IBD (n = 36,375) had higher comorbidities and significantly higher total hospital charges ($48,607 vs $46,661 P <0.001) and longer length of stay (5.2 vs 5 days P <0.001) compared to the non-obese group.

Patients with obesity were also more likely to experience adverse outcomes during hospitalization including cardiac arrest and mechanical ventilation.

The study comes at a time when obesity rates are increasing among patients with IBD.

Related Videos
Jan Wehkamp, MD, PhD: Expanding the Studies of Ustekinumab for IBD
Jan Wehkamp, MD, PhD: New Long-Term Safety Data for Ustekinumab for Ulcerative Colitis
Maria T. Abreu, MD: Promising Initial Data on Guselkumab From ECCO 2023
Laura Wingate: Improving All Aspects of Care for IBD Patients
Katie Falloon, MD: Studying IBD-Associated Peripheral Arthritis
Brad Pasternak, MD: Treating Pediatric COVID-19 Patients With IBD With Paxlovid
Kendall Beck, MD: Promising New Tofacitinib Data From the Crohn's and Colitis Congress
Laura E. Raffals, MD: Sifting Through All the Drug Choices for IBD
Marlana Radcliffe, MD: Treating Ulcerative Colitis Patients With Upadacitinib After Tofacitinib
An Herbal Medicine for Ulcerative Colitis
Related Content
© 2023 MJH Life Sciences

All rights reserved.